Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 – impact on the feasibility of insulinoma internal radiotherapy

[(68)Ga]-DO3A-VS-Cys(40)-Exendin-4 has been shown to be a promising imaging candidate for targeting glucagon like peptide-1 receptor (GLP-1R). In the light of radiotheranostics and personalized medicine the (177)Lu-labelled analogue is of paramount interest. In this study we have investigated the or...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Nucl Med Mol Imaging
Päätekijät: Velikyan, Irina, Bulenga, Thomas N, Selvaraju, Ramkumar, Lubberink, Mark, Espes, Daniel, Rosenström, Ulrika, Eriksson, Olof
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: e-Century Publishing Corporation 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4396004/
https://ncbi.nlm.nih.gov/pubmed/25973333
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia